Literature DB >> 33990391

Cigarette Smoking and Estrogen-Related Cancer.

John A Baron1,2,3, Hazel B Nichols2, Chelsea Anderson2, Stephen Safe4.   

Abstract

Cigarette smoking is a known cause of many cancers, yet epidemiologic studies have found protective associations with the risk of four "estrogen-related" malignancies: endometrial cancer, endometrioid and clear cell ovarian cancers, and thyroid cancer. This review considers epidemiologic and biological aspects of these associations, focusing particularly on estrogen signaling, and contrasts them with those for breast cancer, another estrogen-related malignancy. The observational findings regarding the inverse associations are consistent and remain after adjustment for possible confounding factors. In general, women who smoke do not have lower circulating estrogen levels than nonsmokers, eliminating one possible explanation for reduced risks of these malignancies. For endometrial and endometrioid ovarian cancer, the negative associations could plausibly be explained by interference with signaling through the estrogen receptor α. However, this is unlikely to explain the lower risks of thyroid and clear cell ovarian cancers. For thyroid cancer, an anti-inflammatory effect of nicotine and reduced TSH levels from smoking have been proposed explanations for the inverse association, but both lack convincing evidence. While the overall impact of cigarette smoking is overwhelmingly negative, protective associations such as those discussed here can provide potential clues to disease etiology, treatment, and prevention. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33990391      PMCID: PMC8338753          DOI: 10.1158/1055-9965.EPI-20-1803

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  182 in total

1.  Cigarette smoking and mammographic density in the Danish Diet, Cancer and Health cohort.

Authors:  Katja Kemp Jacobsen; Elsebeth Lynge; Ilse Vejborg; Anne Tjønneland; My von Euler-Chelpin; Zorana J Andersen
Journal:  Cancer Causes Control       Date:  2015-12-08       Impact factor: 2.506

Review 2.  Physiological functions of the cholinergic system in immune cells.

Authors:  Takeshi Fujii; Masato Mashimo; Yasuhiro Moriwaki; Hidemi Misawa; Shiro Ono; Kazuhide Horiguchi; Koichiro Kawashima
Journal:  J Pharmacol Sci       Date:  2017-05-12       Impact factor: 3.337

3.  Correlation of aromatase activity and steroid receptors in human ovarian carcinoma.

Authors:  R Kühnel; J F Delemarre; B R Rao; J G Stolk
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

4.  Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.

Authors:  Da-wei Wang; Rong-bin Zhou; Yong-ming Yao; Xiao-mei Zhu; Yi-mei Yin; Guang-ju Zhao; Ning Dong; Zhi-yong Sheng
Journal:  J Pharmacol Exp Ther       Date:  2010-09-15       Impact factor: 4.030

Review 5.  Adiponectin and smoking status: a systematic review.

Authors:  Kazuhiko Kotani; Ayako Hazama; Akiko Hagimoto; Kumiko Saika; Masako Shigeta; Kota Katanoda; Masakazu Nakamura
Journal:  J Atheroscler Thromb       Date:  2012-05-17       Impact factor: 4.928

6.  The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.

Authors:  Amy L Shafrir; Megan S Rice; Mamta Gupta; Kathryn L Terry; Bernard A Rosner; Rulla M Tamimi; Jonathan L Hecht; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2016-10-05       Impact factor: 5.482

Review 7.  Type I and II endometrial cancers: have they different risk factors?

Authors:  Veronica Wendy Setiawan; Hannah P Yang; Malcolm C Pike; Susan E McCann; Herbert Yu; Yong-Bing Xiang; Alicja Wolk; Nicolas Wentzensen; Noel S Weiss; Penelope M Webb; Piet A van den Brandt; Koen van de Vijver; Pamela J Thompson; Brian L Strom; Amanda B Spurdle; Robert A Soslow; Xiao-ou Shu; Catherine Schairer; Carlotta Sacerdote; Thomas E Rohan; Kim Robien; Harvey A Risch; Fulvio Ricceri; Timothy R Rebbeck; Radhai Rastogi; Jennifer Prescott; Silvia Polidoro; Yikyung Park; Sara H Olson; Kirsten B Moysich; Anthony B Miller; Marjorie L McCullough; Rayna K Matsuno; Anthony M Magliocco; Galina Lurie; Lingeng Lu; Jolanta Lissowska; Xiaolin Liang; James V Lacey; Laurence N Kolonel; Brian E Henderson; Susan E Hankinson; Niclas Håkansson; Marc T Goodman; Mia M Gaudet; Montserrat Garcia-Closas; Christine M Friedenreich; Jo L Freudenheim; Jennifer Doherty; Immaculata De Vivo; Kerry S Courneya; Linda S Cook; Chu Chen; James R Cerhan; Hui Cai; Louise A Brinton; Leslie Bernstein; Kristin E Anderson; Hoda Anton-Culver; Leo J Schouten; Pamela L Horn-Ross
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

Review 8.  Sources of estrogen and their importance.

Authors:  E R Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

Review 9.  Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.

Authors:  V Beral; K Gaitskell; C Hermon; K Moser; G Reeves; R Peto
Journal:  Lancet Oncol       Date:  2012-08-03       Impact factor: 41.316

10.  Cross-Talk in the Female Rat Mammary Gland: Influence of Aryl Hydrocarbon Receptor on Estrogen Receptor Signaling.

Authors:  Janina Helle; Manuela I Bader; Annekathrin M Keiler; Oliver Zierau; Günter Vollmer; Sridar V Chittur; Martin Tenniswood; Georg Kretzschmar
Journal:  Environ Health Perspect       Date:  2015-09-15       Impact factor: 9.031

View more
  1 in total

1.  Cigarette Smoking and Estrogen-Related Cancer-Reply.

Authors:  John A Baron; Hazel B Nichols; Stephen Safe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10       Impact factor: 4.254

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.